
Klaus Pantel/LinkedIn
Dec 4, 2024, 19:03
Residual Disease as a Target for Liquid Biopsy in Patients with Solid Tumours
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a recent article by Klaus Pantel on X:
“Minimal residual disease as a target for liquid biopsy in patients with solid tumours.”
Title: Minimal residual disease as a target for liquid biopsy in patients with solid tumours
Authors: Klaus Pantel and Catherine Alix-Panabières
More posts featuring Yakup Ergün.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 26, 2025, 10:09
Feb 26, 2025, 10:06
Feb 26, 2025, 10:02
Feb 26, 2025, 10:01
Feb 26, 2025, 09:56
Feb 26, 2025, 09:50
Feb 26, 2025, 09:46
Feb 26, 2025, 09:43
Feb 26, 2025, 09:41